In late June, a few days before Disability Pride Month began, I took my 7-year-old child on an outing to an Ikea store. As I ...

The study will assess the efficacy and safety of zorevunersen compared to sham over a 52-week treatment period.

The global Phase III EMPEROR trial (NCT06872125) will evaluate the safety and efficacy of zorevunersen, a novel antisense ...

Stoke Therapeutics Inc (STOK) reports promising advancements in its Dravet syndrome program and strategic partnerships, ...

People who have Dravet syndrome, a rare and severe form of epilepsy, usually experience their first seizure within the first year of life. (1) These early seizures, which are typically triggered ...

Dravet syndrome is a rare genetic epileptic disorder that is due to a brain dysfunction. It usually begins in the first year of an otherwise healthy infant and remains throughout life.

Isabelle Whitehead, a student at Ripon Grammar School, has earned a place to study medicine, inspired by the care given to ...

The Brennan family will host the 7th Annual Dance for Dravet on September 26th at the Third Degree Glass Factory to raise ...

DUBLIN--(BUSINESS WIRE)--The "Dravet Syndrome Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. This report outlays comprehensive insights of present ...

Dravet syndrome, a rare and severe form of epilepsy, affects approximately 1 in 15,700 children. It is primarily caused by mutations in the SCN1A gene, which is crucial for regulating brain activity.

Dravet syndrome is a rare, severe form of epilepsy with symptoms that begin before a child turns 15 months old (and often within the first year of life). (1) Formerly known as severe myoclonic ...